載入中
AMEXHealthcareMedical - Instruments & Supplies
最新資料
US$1.14
+US$0.03 · +2.70%
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
前收盤價
US$1.14
+US$0.03 · +2.70%
盤後
US$1.16
+US$0.02 · +1.75%
10月12日 下午7:49 ET
盤中時間採用ET。市場資料可能有所延遲。
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
日內區間
目前US$1.14
52週區間
目前US$1.14
盤中時間採用ET。市場資料可能有所延遲。
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
日內區間
目前US$1.14
52週區間
目前US$1.14
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 3237.7萬 USD | 2691.8萬 USD | 2677.1萬 USD | 2814.7萬 USD | 3502.1萬 USD |
| 銷貨成本 | 1530.6萬 USD | 1232.4萬 USD | 1191.1萬 USD | 967.7萬 USD | 1178.9萬 USD |
| 毛利 | 1707.1萬 USD | 1459.4萬 USD | 1486萬 USD | 1847萬 USD | 2323.2萬 USD |
| 研究與開發 | 938.3萬 USD | 976萬 USD | 1027.3萬 USD | 1055.8萬 USD | 1019.9萬 USD |
| 銷售、一般及管理費用 | 3029.2萬 USD | 2957.3萬 USD | 2642.6萬 USD | 2668.8萬 USD | 2592.1萬 USD |
| 營業費用 | 3918.3萬 USD | 3933.3萬 USD | 3669.9萬 USD | 3724.6萬 USD | 3612萬 USD |
| 利息收入 | 46.7萬 USD | 69.4萬 USD | 109.6萬 USD | 48.4萬 USD | — |
| 利息支出 | — | — | — | — | 1.01萬 USD |
| 折舊和攤銷 | 155.5萬 USD | 96.9萬 USD | 59.5萬 USD | 42.9萬 USD | 10.6萬 USD |
| 營業利益 | −2211.2萬 USD | −2473.9萬 USD | −2183.9萬 USD | −1877.6萬 USD | −1288.8萬 USD |
| 淨利 | −2164.3萬 USD | −2404.5萬 USD | −2071.3萬 USD | −1829.2萬 USD | −1071.6萬 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$3.50
上漲空間 207.02%| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2013年11月4日 | 137:125 | — | — |
股票分割 | 2012年7月11日 | 1:10 | — | — |
已生效 2013年11月4日
137:125
已生效 2012年7月11日
1:10
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI285.65萬0.00%2.3兆 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM183.9萬0.00%787.4億 USD0.19%US$277.9-0.37%
Vanguard Extended Market ETFVXF141.91萬0.00%954億 USD0.05%US$233.52-0.63%
iShares Russell 2000 Growth ETFIWO70.8萬0.01%139.17億 USD0.24%US$353.71-0.86%
Vanguard Russell 2000 ETFVTWO56.24萬0.00%180億 USD0.06%US$112.27-0.35%
iShares Micro-Cap ETFIWC24.03萬0.02%13.17億 USD0.60%US$181.66-0.73%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM14萬0.12%1.17億 USD0.73%US$15.8484-0.58%
Vanguard Russell 2000 Growth ETFVTWG11.09萬0.01%17億 USD0.06%US$258.28-0.85%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMVanguard Russell 2000 Growth ETFVTWGAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
